This annual Alzheimer's Drug Discovery Foundation conference brings together academic and industry scientists intent on accelerating the development of innovative treatments for Alzheimer’s disease and related dementias.

 

OBJECTIVES

- Highlight scientific progress on drug discovery programs aimed at treating Alzheimer’s disease and related dementias.

- Increase networking opportunities for scientists to share information and resources.

- Foster interdisciplinary and public-private partnerships and alliances.

 

TARGET AUDIENCE

The 2012 edition of this conference attracted attendees from around the world.  Attendees included:

  Academic and industry scientists engaged in drug discovery research for neurodegenerative diseases and CNS

  Business development and licensing professionals

  Alliance management professionals

  Venture capitalists and other investors

Comments